Crossmark

Differentiation therapy for myeloid malignancies: beyond cytotoxicity

Crossref DOI link: https://doi.org/10.1038/s41408-021-00584-3

Published Online: 2021-12-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Stubbins, Ryan J. http://orcid.org/0000-0002-4718-5212
Karsan, Aly http://orcid.org/0000-0001-6753-892X
License Information

Text and Data Mining valid from 2021-12-04

Version of Record valid from 2021-12-04
More Information

Article History

Received: 14 September 2021

Revised: 18 November 2021

Accepted: 19 November 2021

First Online: 4 December 2021

Competing interests

: The authors declare no competing interests.